Samsung Medical Center
Pancreatic cancer treatment cost in the Republic of Korea typically involves complex diagnostic workups, with a PET-CT scan ranging from $1,000 to $1,500. Major surgical interventions, such as Whipple surgery, run from $26,500 to $49,500. Expenses depend on tumor stage, surgical complexity, and the clinic tier. International patients often save 40-60% compared to the US. Most high-specialization treatment centers are located in Seoul and Incheon.
Typical Pancreatic Cancer Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases requiring multidisciplinary care, Seoul National University Hospital (SNUH) is ideal as it serves the South Korean president. Patients seeking advanced technology should consider Samsung Medical Center for IGRT and Da Vinci robotic systems. If digital accuracy is a priority, Seoul National University Bundang Hospital (SNUBH) uses the BESTcare system to minimize medical errors. Specialized oncologists like Dr. Jong Kyun Lee provide expert management for pancreatic and bile duct cancers.
| Republic of Korea | Turkey | Austria | |
| Whipple surgery | from $26,500 | from $23,000 | from $45,000 |
| Proton-beam therapy | from $22,000 | from $70,000 | from $80,000 |
| Pancreatic cancer surgery | from $26,800 | from $9,000 | from $40,000 |
| NanoKnife | from $17,500 | from $9,500 | from $25,000 |
| Gamma Knife | from $13,500 | from $6,300 | from $32,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Pancreatic cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pancreatic cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pancreatic cancer treatment journey.
Professor Kyu Taek Lee specializes in pancreatic, bile duct, and gallbladder cancers at Samsung Medical Center.
Professor Lim Do Hoon leads the Radiation Oncology Department at Samsung Medical Center, specializing in pancreaticobiliary cancer.
Dr. Dong Wook Choi specializes in pancreatic cancer at Samsung Medical Center, with training from top institutions in the US and Japan.
Prof. Jong Kyun Lee is among the best gastroenterologists in South Korea and Asia, specializing in pancreatic, bile duct, and gallbladder cancers.
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital are the premier institutions for pancreatic cancer treatment in South Korea. These facilities are recognized by Newsweek as global leaders in oncology, offering advanced robotic surgery, proton beam therapy, and heavy particle therapy.
Bookimed Expert Insight: While major centers like Asan Medical Center serve over 11,000 outpatients daily, the real advantage for international patients is the surgical specialization. For instance, top oncologists at Samsung Medical Center, such as Dr. Jong Kyun Lee, hold dual degrees from prestigious Korean and US institutions. This high-volume experience directly translates to safer outcomes in complex pancreatic procedures.
Patient Consensus: Patients note South Korea is a preferred destination for aggressive treatment plans combining neoadjuvant chemotherapy with surgery. Many highlight the importance of choosing high-volume centers that perform over 50 Whipple procedures annually to ensure the best recovery results.
Korean surgeons are global leaders in pancreatic surgery, maintaining some of the lowest mortality rates worldwide at 0.2%. Specialists in Seoul-based high-volume centers commonly perform over 2,000 procedures each, utilizing advanced da Vinci robotic systems and pioneering domestic technologies like the Revo-i.
Bookimed Expert Insight: While many countries offer oncology care, South Korea’s scale is unique. Asan Medical Center alone performs over 65,000 operations annually across 88 departments. This massive patient volume allows surgeons to specialize narrow-deep; for instance, Dr. Dong Wook Choi and Professor Lim Do Hoon at Samsung Medical Center focus specifically on hepatobiliary-pancreatic cancers, reaching expertise levels rarely seen in lower-volume European or American facilities.
Patient Consensus: Patients note that recovery from robotic pancreatic surgery in Seoul can be twice as fast as traditional methods. Many recommend using medical coordinators to manage communications with high-volume hospitals like Samsung or Severance.
The 5-year relative survival rate for pancreatic cancer in South Korea recently reached 15.2% for patients diagnosed between 2016 and 2020. This marks a significant improvement from 8.6% a decade prior, surpassing survival rates typically reported in the United States and Europe.
Bookimed Expert Insight: While overall survival is 15.2%, choosing high-volume centers like Samsung Medical Center or Asan Medical Center is critical. Our data shows Samsung Medical Center alone serves over 2 million patients annually and maintains a dedicated Comprehensive Cancer Center. These specialized hubs utilize technologies like the Da Vinci surgical system and Novalis, which are essential for the complex Whipple procedures that significantly drive up individual survival odds.
Patient Consensus: Patients note that while Korean centers provide excellent care, survival is heavily tied to catching the cancer early enough for surgery. Those treated at major hospitals like Severance emphasize that high-volume centers offer better technical outcomes for stage II cases.
Advanced surgical techniques for pancreatic cancer in South Korea center on high-precision robotic resections and minimally invasive methods. Facilities like Samsung Medical Center and Severance Hospital utilize the da Vinci surgical system to perform complex Whipple procedures, aiming for targeted tumor removal with reduced recovery times.
Bookimed Expert Insight: Analysis of clinical data shows that Korea's lead in digital integration, such as the BESTcare system at Seoul National University Bundang Hospital, significantly reduces surgical errors. While high-volume centers like Asan Medical Center perform over 65,000 operations annually, patients benefit most from the 90% success rate in complex organ-related procedures found at these top-tier academic institutions.
Patient Consensus: Patients note that choosing robotic-assisted Whipple procedures often cuts hospital stays in half compared to traditional open surgery. Many suggest bringing pathology slides for a second opinion via telemedicine to confirm eligibility for advanced treatments like NanoKnife.
South Korean oncology centers provide advanced non-surgical alternatives for pancreatic cancer, including Proton-beam therapy, CyberKnife, and NanoKnife. These specialized radiation and ablation techniques target tumors with extreme precision, minimizing damage to the surrounding duodenum and major blood vessels while offering options for inoperable cases.
Bookimed Expert Insight: Data suggests that choosing centers like Samsung Medical Center or Seoul National University Hospital provides access to integrated departments where radiation oncologists and gastroenterologists collaborate. Specialists such as Dr. Lim Do Hoon at Samsung Medical Center lead dedicated radiation oncology units, ensuring that non-surgical protocols are synchronized with advanced diagnostics like PET/CT for better tracking of tumor response.
Patient Consensus: Patients note that using advanced technologies like SBRT can lead to visible tumor shrinkage and often allows for a faster return to daily activities. Many emphasize the importance of contacting international departments early to coordinate these high-tech treatments and arrange necessary interpreter services.
Korean doctors treat stage 4 pancreatic cancer using multidisciplinary strategies combining chemotherapy, heavy ion therapy, and targeted treatments. Facilities like Samsung Medical Center and Asan Medical Center utilize genomic testing to tailor BRCA/KRAS therapies, aiming to prolong life and manage metastatic symptoms effectively.
Bookimed Expert Insight: Data from top-tier Seoul facilities like Samsung Medical Center, which serves over 2,000,000 patients annually, shows a shift toward digitalization to eliminate medical errors. For stage 4 cases, the most effective approach combines traditional oncology with rapid genomic profiling. This allows doctors to match patients with specific immunotherapy trials that are often covered by domestic insurance structures, potentially extending life beyond standard chemotherapy outcomes.
Patient Consensus: Patients note that while the disease remains aggressive, Korean hospitals provide better access to targeted drug combinations and clinical trials. Many emphasize the need for genomic testing before traveling to ensure the treatment plan matches their specific tumor markers.
Major South Korean hospitals provide comprehensive services for foreigners through dedicated international healthcare centers. These facilities offer multilingual coordination, medical visa assistance, and specialized oncology departments accredited by JCI and KOIHA. Top institutions like Asan Medical Center and Samsung Medical Center serve thousands of global patients annually.
Bookimed Expert Insight: Korea's medical landscape shows a distinct pattern where top-tier hospitals like Seoul National University Hospital and Samsung Medical Center act as presidential-standard facilities. Our data indicates these centers often provide faster access to PET/CT scans and biopsies than many Western systems. For pancreatic cases, focusing on clinics with high annual operation counts, such as Asan's 65,000+ procedures, correlates with better managed complex surgical outcomes.
Patient Consensus: Patients note that while international wings offer excellent English support, using translation apps like Papago is helpful for communication in general hospital wards. Many emphasize the importance of preparing apostilled medical documents early to avoid visa processing delays of up to 4 weeks.